» Articles » PMID: 33573353

ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?

Overview
Journal Biomolecules
Publisher MDPI
Date 2021 Feb 12
PMID 33573353
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The unfolded protein response (UPR) is an evolutionarily conserved adaptive signaling pathway triggered by a stress of the endoplasmic reticulum (ER) lumen compartment, which is initiated by the accumulation of unfolded proteins. This response, mediated by three sensors-Inositol Requiring Enzyme 1 (IRE1), Activating Transcription Factor 6 (ATF6), and Protein Kinase RNA-Like Endoplasmic Reticulum Kinase (PERK)-allows restoring protein homeostasis and maintaining cell survival. UPR represents a major cytoprotective signaling network for cancer cells, which frequently experience disturbed proteostasis owing to their rapid proliferation in an usually unfavorable microenvironment. Increased basal UPR also participates in the resistance of tumor cells against chemotherapy. UPR activation also occurs during hematopoiesis, and growing evidence supports the critical cytoprotective role played by ER stress in the emergence and proliferation of leukemic cells. In case of severe or prolonged stress, pro-survival UPR may however evolve into a cell death program called terminal UPR. Interestingly, a large number of studies have revealed that the induction of proapoptotic UPR can also strongly contribute to the sensitization of leukemic cells to chemotherapy. Here, we review the current knowledge on the consequences of the deregulation of UPR signaling in leukemias and their implications for the treatment of these diseases.

Citing Articles

PERK-Olating Through Cancer: A Brew of Cellular Decisions.

Mazzolini L, Touriol C Biomolecules. 2025; 15(2).

PMID: 40001551 PMC: 11852789. DOI: 10.3390/biom15020248.


Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis.

Sun X, Li Y, Du J, Liu F, Wu C, Xiao W Nat Commun. 2025; 16(1):1358.

PMID: 39905002 PMC: 11794619. DOI: 10.1038/s41467-025-56520-7.


Improving data interpretability with new differential sample variance gene set tests.

Rahmatallah Y, Glazko G Res Sq. 2024; .

PMID: 39315246 PMC: 11419169. DOI: 10.21203/rs.3.rs-4888767/v1.


Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins.

Halilovic M, Abdelsalam M, Zabkiewicz J, Lazenby M, Alvares C, Schmidt M Leukemia. 2024; 38(12):2561-2572.

PMID: 39300221 PMC: 11588663. DOI: 10.1038/s41375-024-02405-5.


Megakaryocyte maturation involves activation of the adaptive unfolded protein response.

Faiz M, Kalev-Zylinska M, Dunstan-Harrison C, Singleton D, Hay M, Ledgerwood E Genes Cells. 2024; 29(10):889-901.

PMID: 39138929 PMC: 11555628. DOI: 10.1111/gtc.13151.


References
1.
Prada-Arismendy J, Arroyave J, Rothlisberger S . Molecular biomarkers in acute myeloid leukemia. Blood Rev. 2016; 31(1):63-76. DOI: 10.1016/j.blre.2016.08.005. View

2.
Ng A, Chng W, Khan M . Curcumin sensitizes acute promyelocytic leukemia cells to unfolded protein response-induced apoptosis by blocking the loss of misfolded N-CoR protein. Mol Cancer Res. 2011; 9(7):878-88. DOI: 10.1158/1541-7786.MCR-10-0545. View

3.
Brancolini C, Iuliano L . Proteotoxic Stress and Cell Death in Cancer Cells. Cancers (Basel). 2020; 12(9). PMC: 7563887. DOI: 10.3390/cancers12092385. View

4.
Rodriguez-Vicente A, Diaz M, Hernandez-Rivas J . Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease. Cancer Genet. 2013; 206(3):49-62. DOI: 10.1016/j.cancergen.2013.01.003. View

5.
Guo F, Lin E, Liu P, Lin J, Liu C . XBP1U inhibits the XBP1S-mediated upregulation of the iNOS gene expression in mammalian ER stress response. Cell Signal. 2010; 22(12):1818-28. DOI: 10.1016/j.cellsig.2010.07.006. View